Disseminated Cryptococcal Disease in a Patient With Monoclonal Gammopathy of Undetermined Significance and Polycythemia Vera: A Case Report and Review of the Literature
暂无分享,去创建一个
[1] D. Richman,et al. A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinib , 2019, BMC Infectious Diseases.
[2] Z. Chagla,et al. Disseminated Cryptococcal Disease in Non-HIV, Nontransplant Patient , 2016, Case reports in infectious diseases.
[3] Chiung-Yu Huang,et al. Cryptococcus Infection Network in Non-Human Immunodeficiency Virus Cohort (CINCH) Study: Initial Report of Treatment and Outcomes , 2016, Open forum infectious diseases.
[4] S. Holland,et al. Anti–GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis , 2013, The Journal of Immunology.
[5] J. Baddley,et al. Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status , 2013, PloS one.
[6] S. Antinori. New Insights into HIV/AIDS-Associated Cryptococcosis , 2013, ISRN AIDS.
[7] J. Perfect,et al. Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant , 2012, PloS one.
[8] V. Yu,et al. Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study. , 2010, The Journal of infection.
[9] J. Perfect,et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] L. Goldani,et al. Histopathological Aspects of Neurocryptococcosis in HIV-Infected Patients: Autopsy Report of 45 Patients , 2009, International journal of surgical pathology.
[11] I. Schmalfuss,et al. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] R. M. Warren,et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] S. Krähenbühl,et al. Primary Cutaneous Cryptococcosis in aPatient with Systemic Immunosuppression after Liver Transplantation , 2000, Dermatology.
[14] T. Sorrell,et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] A. Casadevall,et al. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] R. Diasio,et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. , 1987, The New England journal of medicine.
[17] A. Forrestel,et al. CRYPTOCOCCOSIS , 1982, The Lancet.
[18] C. Kauffman,et al. Detection of cryptococcal antigen. Comparison of two latex agglutination tests. , 1981, American journal of clinical pathology.